We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current UNCY market cap is 61.48M. The company's latest EPS is USD -0.2772 and P/E is -1.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.94M | -6.31M | -9.2M | -7.4M | -6.25M |
| Net Income | -4.41M | -7.8M | -21.17M | 8.97M | -4.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 951k | 675k |
| Operating Income | -1.96M | -2.02M | -8.98M | -18.05M | -20.77M |
| Net Income | -2.17M | -2.26M | -10.02M | -18.06M | -31.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.44M | 14.19M | 52.39M | 44.7M | 38.57M |
| Total Liabilities | 16.01M | 18M | 30.65M | 13.36M | 10.72M |
| Total Equity | 3.39M | -3.81M | -24.46M | -14.85M | 27.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19k | 204k | 18.74M | 2.82M | 14.19M |
| Total Liabilities | 903k | 2.88M | 2.26M | 3.28M | 18M |
| Total Equity | -884k | -2.67M | 16.48M | -466k | -3.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.84M | -18.28M | -6.46M | -12.78M | -22.03M |
| Investing | -12k | -12k | -6k | -26k | -50k |
| Financing | 27.75M | 27.54M | 45.69M | 44.88M | 44.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.18M | -1.46M | -5.77M | -15.65M | -18.28M |
| Investing | N/A | N/A | -29k | -2k | -12k |
| Financing | 1.17M | 1.44M | 22.38M | -471k | 27.54M |
| Market Cap | 61.48M |
| Price to Earnings Ratio | -1.95 |
| Price to Sales Ratio | 90 |
| Price to Cash Ratio | 6.31 |
| Price to Book Ratio | -16.07 |
| Dividend Yield | - |
| Shares Outstanding | 113.32M |
| Average Volume (1 week) | 967.48k |
| Average Volume (1 Month) | 1.16M |
| 52 Week Change | -43.19% |
| 52 Week High | 1.818 |
| 52 Week Low | 0.202 |
| Spread (Intraday) | 0 (0.46%) |
| Company Name | Unicycive Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unicycive.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
